# Incidence of Diabetes After a COVID-19 Infection

> **NCT05524792** · — · COMPLETED · sponsor: **InGef - Institute for Applied Health Research Berlin GmbH** · enrollment: 157134 (actual)

## Conditions studied

- COVID-19
- Diabetes Mellitus

## Interventions

- **OTHER:** no interventional study

## Key facts

- **NCT ID:** NCT05524792
- **Lead sponsor:** InGef - Institute for Applied Health Research Berlin GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 157134 (ACTUAL)
- **Last updated:** 2024-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524792, "Incidence of Diabetes After a COVID-19 Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05524792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*